BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 31529852)

  • 1. Multidrug resistance and risk factors associated with community-acquired urinary tract infections caused by Escherichia coli in Venezuela.
    Guzmán M; Salazar E; Cordero V; Castro A; Villanueva A; Rodulfo H; De Donato M
    Biomedica; 2019 May; 39(s1):96-107. PubMed ID: 31529852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and types of extended spectrum β-lactamases among urinary Escherichia coli isolates in Moroccan community.
    Barguigua A; El Otmani F; Talmi M; Zerouali K; Timinouni M
    Microb Pathog; 2013; 61-62():16-22. PubMed ID: 23643553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characteristics and antibiotic resistance profiles of Escherichia coli strains isolated from urinary tract infections in children admitted to children's referral hospital of Qom, Iran.
    Pourakbari B; Mamishi S; Shokrollahi MR; Heydari H; Mahmoudi S; Banar M; Sadeghi RH; Movahedi Z
    Ann Ig; 2019; 31(3):252-262. PubMed ID: 31069370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of beta-lactamase CTX-M-15 in phylogenetic groups of uropathogenic Escherichia coli isolated from patients in the community of Merida, Venezuela].
    Hernández E; Araque M; Millán Y; Millán B; Vielma S
    Invest Clin; 2014 Mar; 55(1):32-43. PubMed ID: 24758100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
    J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial Resistance and Molecular Characterization of Extended-Spectrum β-Lactamases of Escherichia coli and Klebsiella spp. Isolates from Urinary Tract Infections in Southern Brazil.
    Pereira JL; Volcão LM; Klafke GB; Vieira RS; Gonçalves CV; Ramis IB; da Silva PEA; von Groll A
    Microb Drug Resist; 2019 Mar; 25(2):173-181. PubMed ID: 30133334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections.
    Smet A; Martel A; Persoons D; Dewulf J; Heyndrickx M; Claeys G; Lontie M; Van Meensel B; Herman L; Haesebrouck F; Butaye P
    Microb Drug Resist; 2010 Jun; 16(2):129-34. PubMed ID: 20370505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
    Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
    N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large U.S. Medical Center.
    Hayakawa K; Gattu S; Marchaim D; Bhargava A; Palla M; Alshabani K; Gudur UM; Pulluru H; Bathina P; Sundaragiri PR; Sarkar M; Kakarlapudi H; Ramasamy B; Nanjireddy P; Mohin S; Dasagi M; Datla S; Kuchipudi V; Reddy S; Shahani S; Upputuri V; Marrey S; Gannamani V; Madhanagopal N; Annangi S; Sudha B; Muppavarapu KS; Moshos JA; Lephart PR; Pogue JM; Bush K; Kaye KS
    Antimicrob Agents Chemother; 2013 Aug; 57(8):4010-8. PubMed ID: 23752516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of extended spectrum-β-lactamase-producing Escherichia coli O25b-ST131: a major community-acquired uropathogen in infants.
    Cheng MF; Chen WL; Hung WY; Huang IF; Chiou YH; Chen YS; Lee SS; Hung CH; Wang JL
    Pediatr Infect Dis J; 2015 May; 34(5):469-75. PubMed ID: 25879646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and quinolone resistance of fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli in 6 communities and 2 physical examination center populations in Shanghai, China.
    Ni Q; Tian Y; Zhang L; Jiang C; Dong D; Li Z; Mao E; Peng Y
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):428-433. PubMed ID: 27681363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of Extended-spectrum β lactamase- producing E. coli recovered from community-acquired urinary tract infections in Upper Egypt.
    Hassuna NA; Khairalla AS; Farahat EM; Hammad AM; Abdel-Fattah M
    Sci Rep; 2020 Feb; 10(1):2772. PubMed ID: 32066805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence and risk factors for extended-spectrum β-lactamase-producing Escherichia coli causing community-onset urinary tract infections in Colombia].
    Blanco VM; Maya JJ; Correa A; Perenguez M; Muñoz JS; Motoa G; Pallares CJ; Rosso F; Matta L; Celis Y; Garzon M; Villegas MV
    Enferm Infecc Microbiol Clin; 2016 Nov; 34(9):559-565. PubMed ID: 26774256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children.
    Fan NC; Chen HH; Chen CL; Ou LS; Lin TY; Tsai MH; Chiu CH
    J Microbiol Immunol Infect; 2014 Oct; 47(5):399-405. PubMed ID: 23834784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of fluoroquinolone-resistant and broad-spectrum cephalosporin-resistant community-acquired urinary tract infections in Rio de Janeiro: Impact of Escherichia coli genotypes ST69 and ST131.
    de Souza da-Silva AP; de Sousa VS; de Araújo Longo LG; Caldera S; Baltazar ICL; Bonelli RR; Santoro-Lopes G; Riley LW; Moreira BM
    Infect Genet Evol; 2020 Nov; 85():104452. PubMed ID: 32634601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug resistance dissemination by extended-spectrum β-lactamase-producing Escherichia coli causing community-acquired urinary tract infection in the Central-Western Region, Brazil.
    Gonçalves LF; de Oliveira Martins-Júnior P; de Melo ABF; da Silva RCRM; de Paulo Martins V; Pitondo-Silva A; de Campos TA
    J Glob Antimicrob Resist; 2016 Sep; 6():1-4. PubMed ID: 27530830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of ST131 among CTX-M-producing Escherichia coli from community-acquired infections, in the Czech Republic.
    Papagiannitsis CC; Študentová V; Jakubů V; Španělová P; Urbášková P; Žemličková H; Hrabák J
    Microb Drug Resist; 2015 Feb; 21(1):74-84. PubMed ID: 25188031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community emergence of CTX-M type extended-spectrum beta-lactamases among urinary Escherichia coli from women.
    Ho PL; Poon WW; Loke SL; Leung MS; Chow KH; Wong RC; Yip KS; Lai EL; Tsang KW;
    J Antimicrob Chemother; 2007 Jul; 60(1):140-4. PubMed ID: 17496058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of ESBLs among Escherichia coli isolates from outpatients with recurrent UTIs and their antimicrobial resistance.
    Al-Mayahie S; Al Kuriashy JJ
    J Infect Dev Ctries; 2016 Jun; 10(6):575-83. PubMed ID: 27367005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of quinolone and beta-lactam resistance among Escherichia coli strains isolated from urinary tract infections.
    Tayebi Z; Heidari H; Kazemian H; Ghafoori SM; Boroumandi S; Houri H
    Infez Med; 2016 Dec; 24(4):326-330. PubMed ID: 28011969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.